Trevi Therapeutics (TRVI) Other Non-Current Assets (2018 - 2026)

Trevi Therapeutics' Other Non-Current Assets history runs 9 years deep, the most recent figure standing at $2.6 million for Q1 2026.

• On a quarterly basis, Other Non-Current Assets rose 982.99% year-over-year to $2.6 million in Q1 2026; TTM through Mar 2026 was $2.6 million, a 982.99% increase from a year earlier, with the FY2025 full-year figure at $928000.0, up 281.89% from the prior year.
• Other Non-Current Assets climbed to $2.6 million in Q1 2026 per TRVI's latest filing, from $928000.0 in the prior quarter.
• Across five years, Other Non-Current Assets topped out at $2.6 million in Q1 2026 and bottomed at $68000.0 in Q2 2023.
• The 5-year median for Other Non-Current Assets is $273000.0 (2024), against an average of $462235.3.
• Across the five-year window, Other Non-Current Assets slumped 83.54% in 2023 and surged 982.99% in 2026, its largest moves.
• Year by year, Other Non-Current Assets stood at $205000.0 in 2022, then surged by 44.88% to $297000.0 in 2023, then declined by 18.18% to $243000.0 in 2024, then soared by 281.89% to $928000.0 in 2025, then soared by 181.25% to $2.6 million in 2026.
• Per Business Quant, the three latest TRVI Other Non-Current Assets figures stand at $2.6 million (Q1 2026), $928000.0 (Q4 2025), and $103000.0 (Q3 2025).